12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Influsplit Tetra regulatory update

GlaxoSmithKline said it received FDA approval to begin shipping Fluarix Quadrivalent seasonal flu vaccine to U.S. Centers for Disease Control and Prevention (CDC) distribution centers and U.S. healthcare providers for the 2013-2014 flu season. GSK said the CDC...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >